235 related articles for article (PubMed ID: 17326255)
1. Docetaxel-induced onycholysis: the role of subungual hemorrhage and suppuration.
Roh MR; Cho JY; Lew W
Yonsei Med J; 2007 Feb; 48(1):124-6. PubMed ID: 17326255
[TBL] [Abstract][Full Text] [Related]
2. Subungueal haemorrhages following docetaxel (taxotere) treatment.
Fenniche S; Hammami H; Badri T; Mokhtar I; Benmously R
Curr Drug Saf; 2012 Jul; 7(3):247-9. PubMed ID: 22950986
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.
Yorulmaz A; Dogan M; Artuz F; Zengin N
Cutan Ocul Toxicol; 2017 Jun; 36(2):135-139. PubMed ID: 27086693
[TBL] [Abstract][Full Text] [Related]
4. Nail changes secondary to docetaxel (Taxotere).
Correia O; Azevedo C; Pinto Ferreira E; Braga Cruz F; Polónia J
Dermatology; 1999; 198(3):288-90. PubMed ID: 10393455
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel-induced subungual hemorrhage.
Vanhooteghem O; André J; Vindevoghel A; Vandenbossche L; Vandeveire A; Song M
Dermatology; 1997; 194(4):419-20. PubMed ID: 9252781
[TBL] [Abstract][Full Text] [Related]
6. Onycholysis and subungual haemorrhages secondary to systemic chemotherapy (paclitaxel).
Ghetti E; Piraccini BM; Tosti A
J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):459-60. PubMed ID: 12834462
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-associated subungual pyogenic granuloma: report in a patient with breast cancer receiving paclitaxel and review of drug-induced pyogenic granulomas adjacent to and beneath the nail.
Paul LJ; Cohen PR
J Drugs Dermatol; 2012 Feb; 11(2):262-8. PubMed ID: 22270214
[TBL] [Abstract][Full Text] [Related]
8. Taxane-induced nail changes: incidence, clinical presentation and outcome.
Minisini AM; Tosti A; Sobrero AF; Mansutti M; Piraccini BM; Sacco C; Puglisi F
Ann Oncol; 2003 Feb; 14(2):333-7. PubMed ID: 12562663
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel-induced nail dystrophy.
Nicolopoulos J; Howard A
Australas J Dermatol; 2002 Nov; 43(4):293-6. PubMed ID: 12423438
[TBL] [Abstract][Full Text] [Related]
10. [Onycholysis due to docetaxel in breast cancer treatment].
Grasland A; Grandjean M; Rist S; Bosquet A; Vinceneux P
Rev Med Interne; 2005 May; 26(5):427-8. PubMed ID: 15893036
[No Abstract] [Full Text] [Related]
11. Medical Pearl: Docetaxel-induced onycholysis.
Tinio P; Bershad S; Levitt JO
J Am Acad Dermatol; 2005 Feb; 52(2):350-1. PubMed ID: 15692485
[No Abstract] [Full Text] [Related]
12. Drug-related nail disease.
Piraccini BM; Alessandrini A
Clin Dermatol; 2013; 31(5):618-26. PubMed ID: 24079591
[TBL] [Abstract][Full Text] [Related]
13. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
Can G; Aydiner A; Cavdar I
Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
[TBL] [Abstract][Full Text] [Related]
14. Nail changes during docetaxel containing combination chemotherapy.
Woo IS; Shim KH; Kim GY; Lee MA; Kang JH; Hong YS; Lee KS
Korean J Intern Med; 2004 Jun; 19(2):132-3. PubMed ID: 15366647
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel-induced onycholysis.
Prabhash K; Babu KG; Ravi S; Girish MH; Bapsy PP
J Assoc Physicians India; 2004 Feb; 52():167-8. PubMed ID: 15656060
[No Abstract] [Full Text] [Related]
16. A rare manifestation of nail changes with docetaxel therapy.
Halvorson CR; Erickson CL; Gaspari AA
Skinmed; 2010; 8(3):179-80. PubMed ID: 21137627
[TBL] [Abstract][Full Text] [Related]
17. [Examination about the influence for daily life that nail and skin disorders induced by docetaxel in patients with breast cancer].
Kohama K; Masuda N; Yamamura J; Ishitobi M; Masuda H; Ogawa M; Todaka K; Tanaka T; Ueno H; Nakamori S; Tsujinaka T
Gan To Kagaku Ryoho; 2009 Apr; 36(4):615-8. PubMed ID: 19381034
[TBL] [Abstract][Full Text] [Related]
18. Nail toxicities induced by systemic anticancer treatments.
Robert C; Sibaud V; Mateus C; Verschoore M; Charles C; Lanoy E; Baran R
Lancet Oncol; 2015 Apr; 16(4):e181-9. PubMed ID: 25846098
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel-induced palmoplantar erythrodysesthesia syndrome and long-lasting multiple nail changes.
Akoglu G
Indian J Pharmacol; 2014; 46(2):225-7. PubMed ID: 24741199
[TBL] [Abstract][Full Text] [Related]
20. Severe nail changes due to Docetaxel treatment.
Rafi L; Friedrich M; Tilgen W; Reichrath J
Eur J Dermatol; 2003; 13(6):610-1. PubMed ID: 14721789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
